In recent years, an increasing number of studies have shown that ASPM is highly expressed not only in central nervous system tumors, but also in a variety of solid tumors, such as prostate cancer (15), breast cancer (16), and bladder cancer (17). This evidence concerns the gene ASPM and prostate carcinoma.